Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


Asia’s IPO Market Set for Strong Growth as China and India Drive Investor Diversification
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates
Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit
Spain’s Industrial Output Records Steady Growth in October Amid Revised September Figures
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 



